Home » Topics » Disease categories and therapies » Immune

Immune
RSS

VaxGen and Kaketsuken sign agreement for smallpox vaccine development

Dec. 27, 2002

Alliance and Mixture Sciences enter technology license agreement

Dec. 27, 2002

Shigella vaccine is safe and immunogenic in phase I trial

Dec. 27, 2002

Incell develops oral smallpox vaccine

Dec. 23, 2002

Coley receives funding to develop CpG oligos for enhancement of vaccines

Dec. 20, 2002

VRBPAC recommends the FDA approve intranasal influenza vaccine

Dec. 18, 2002

Approval granted by FDA for GlaxoSmithKline's Pediarix combination vaccine

Dec. 18, 2002

AMD-3100 enters phase II in combination with G-CSF for stem cell transplantation

Dec. 17, 2002

CholeraGarde vaccine enters phase II trial in Bangladesh

Dec. 17, 2002

Veronate granted fast track status

Dec. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...